Darren Craig Jones

Papers

1

Total Citations

58

H-Index

1

About

Darren Craig Jones is a leading figure in the field of high-throughput screening and assay development, with a particular focus on the precision and reproducibility of compound management in drug discovery. His most notable contribution is the validation of acoustic droplet ejection (ADE) technology for cell-based screening, a breakthrough that addressed a critical bottleneck in early-stage pharmaceutical research. In his landmark 2009 paper, "Achieving Accurate Compound Concentration in Cell-Based Screening: Validation of Acoustic Droplet Ejection Technology," Jones demonstrated how ADE could deliver nanoliter volumes of compounds directly into assay plates with unparalleled accuracy, eliminating the need for intermediate dilution steps and reducing compound waste. This work, which has garnered 58 citations, has been instrumental in standardizing liquid handling protocols across the industry, enabling more reliable dose-response curves and higher-quality screening data. Jones’s research has directly influenced the design of modern automated screening platforms, and his validation studies remain a cornerstone reference for laboratories seeking to implement acoustic dispensing. His achievements underscore a career dedicated to bridging the gap between technological innovation and practical application in biomedical research.

Research Focus

Key Achievements

1
H-Index
1
Papers
58
Total Citations
58
Avg Citations/Paper
🏆 Most Cited Paper
Achieving Accurate Compound Concentration in Cell-Based Screening: Validation of Acoustic Droplet Ejection Technology
58 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 6

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago